- The National Institutes of Health has doled out nearly $46 million in taxpayer funds to 100 Chinese institutions in the form of subgrants since fiscal year 2012, federal data shows.
- 27 of the Chinese organizations, including the Wuhan Institute of Virology, received funds from Dr. Anthony Fauci’s NIH subagency to perform research on infectious diseases, the data shows.
- One of the subgrants from Fauci’s subagency to a Chinese government-owned institution explicitly states that the U.S. will only receive taxpayer-funded research data upon approval by Chinese government authorities.
- A bipartisan group of senators wrote a letter to President Joe Biden on Tuesday questioning why the U.S. is funding research in a country that has violated international health regulations, has stonewalled inquiries into the origin of COVID-19 and that may be in violation of the Biological Weapons Convention.
The National Institutes of Health has doled out nearly $46 million in taxpayer funds to 100 Chinese institutions in the form of subgrants since the 2012 fiscal year to conduct research into infectious diseases, drug addiction, mental health and other scientific fields, according to a Daily Caller News Foundation analysis of federal spending data.
The NIH’s ongoing funding of Chinese research institutions comes amid growing bipartisan concern in Washington D.C. over the fact that U.S. taxpayers support research in a country that has violated international health regulations, stonewalled a proper investigation into the origins of COVID-19 and that may be in violation of the Biological Weapons Convention.
The National Institute of Allergy and Infectious Diseases, the NIH subagency led by Dr. Anthony Fauci, provided $6.6 million in taxpayer-funded subgrants to 27 of the Chinese entities, including the Wuhan Institute of Virology, to conduct research into allergies and infectious diseases, subgrant data pulled from USASpending.gov shows.
One of the NIAID-funded subgrants, which involved the transfer of $428,000 to a Chinese government-owned institution in 2020 to conduct research into emerging mosquito and tick-based infections, states unequivocally that the U.S. will only receive the research, funded in part by U.S. taxpayers, upon approval by Chinese government authorities.
“Following testing for common pathogens, and then, after approval by the relevant authorities of the Chinese government, a subset of samples will be sent to Washington University in St. Louis for further analysis,” the subgrant description to the Chinese National Institute for Viral Disease Control and Prevention reads.
The NIH did not return a request for comment.
Another NIAID-funded project provided $600,000 in subgrants to the Wuhan Institute of Virology prior to the COVID-19 pandemic to conduct research that involved the genetic modification of bat-based coronaviruses. (RELATED: US Grant To Wuhan Lab To Enhance Bat-Based Coronaviruses Was Never Scrutinized By HHS Review Board, NIH Says)
A House Energy and Commerce Committee aide told the DCNF that their investigation shows that USASpending subaward data is incomplete and underreported, meaning the NIH’s funding of Chinese institutions could be higher than available reporting currently shows.
Fauci has defended his agency’s funding of the Wuhan lab amid growing concern that it could be linked to the COVID-19 outbreak, saying it would have been “negligent” for his agency not to do so.
“We have always been very careful. And, looking forward, we will continue to be very careful in what we do,” Fauci said when asked by CNN’s Jake Tapper on Sunday if his agency will continue to collaborate with Chinese institutions in light of China’s resistance to a transparent investigation into the origins of COVID-19.
Fauci has vehemently rejected accusations from members of the scientific community and Republican lawmakers that his agency funded risky gain-of-function experiments at the Wuhan lab, a form of research that involves the deliberate modification of dangerous pathogens to make them more infectious towards humans.
A growing cadre of lawmakers on both sides of the aisle has expressed concern over the possibility that the U.S. is funding scientific research in China that could lead to its own demise.
The State Department issued a fact sheet in May 2020 revealing that the Chinese Communist Party has engaged in a national strategy of “military-Civil Fusion” intended to eliminate barriers between civilian research and the Chinese military “in order to achieve military dominance.”
“In a clandestine and non-transparent manner, the CCP is acquiring the intellectual property, key research, and technological advancements of the world’s citizens, researchers, scholars, and private industry in order to advance military aims,” the fact sheet stated. “Joint research institutions, academia, and private firms are all being exploited to build the [People’s Liberation Army’s] future military systems — often without their knowledge or consent.”
Democratic Sens. Bob Menendez of New Jersey and Mark Warner of Virginia joined Republican Sens. Jim Risch of Idaho and Marco Rubio of Florida in a letter to President Joe Biden on Tuesday demanding a complete review of all government funding of Chinese entities engaged in research that poses dual-use concerns.
“U.S. taxpayer funding should not support any collaboration with [People’s Republic of China] entities that pose health, economic or security risks for the United States,” the senators wrote. “The PRC has demonstrated lax biosecurity standards, violated the International Health Regulations (2005), attempted to steal intellectual property related to COVID-19 vaccines, and may be in violation of the Biological Weapons Convention.”
“The United States should not be partnering with or funding any country that exhibits these risk factors,” the senators wrote.
| National Institutes of Health Funding Program | Total Subgrants to Chinese Entities FY2012 – FY2021 |
|---|---|
| 93.242: MENTAL HEALTH RESEARCH GRANTS | $9,084,941.00 |
| 93.393: CANCER CAUSE AND PREVENTION RESEARCH | $5,354,952.00 |
| 93.865: CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | $4,399,391.12 |
| 93.855: ALLERGY AND INFECTIOUS DISEASES RESEARCH; 93.855: ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH | $4,069,720.10 |
| 93.839: BLOOD DISEASES AND RESOURCES RESEARCH | $4,041,377.00 |
| 93.989: INTERNATIONAL RESEARCH AND RESEARCH TRAINING | $3,979,684.72 |
| 93.113: ENVIRONMENTAL HEALTH | $2,838,509.20 |
| 93.279: DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | $2,796,834.00 |
| 93.855: ALLERGY AND INFECTIOUS DISEASES RESEARCH | $1,541,010.00 |
| 93.853: EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | $1,339,148.00 |
| 93.395: CANCER TREATMENT RESEARCH | $1,216,232.00 |
| 93.847: DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | $1,061,700.00 |
| 93.855: ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH | $968,767.00 |
| 93.394: CANCER DETECTION AND DIAGNOSIS RESEARCH | $749,405.00 |
| 93.173: RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS | $714,298.00 |
| 93.859: BIOMEDICAL RESEARCH AND RESEARCH TRAINING | $503,630.00 |
| 93.838: LUNG DISEASES RESEARCH | $298,947.00 |
| 93.396: CANCER BIOLOGY RESEARCH | $288,600.00 |
| 93.866: AGING RESEARCH | $279,531.00 |
| 93.286: DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH | $162,000.00 |
| 93.361: NURSING RESEARCH | $147,471.00 |
| 93.121: ORAL DISEASES AND DISORDERS RESEARCH | $86,922.00 |
| 93.853: EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDE; 93.853: EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | $6,992.00 |
(Source: USASpending.Gov)
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.
